ALNY Dec 2025 230.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

60.00

0.00

(0.00%)

As of 03:06PM EDT. Market open.

Loading interactive chart…

Zacks
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Alnylam Pharmaceuticals (ALNY) and Alimera Sciences, Inc. (ALIM) are in the spotlight following study and merger updates, respectively.
Zacks
Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Alnylam (ALNY) soars as its phase III study, seeking to expand Anvuttra's label to include the treatment of ATTR amyloidosis with cardiomyopathy, achieves primary and all secondary endpoints.
Simply Wall St.
Top Three US Stocks Estimated Below Intrinsic Value In June 2024
As of June 2024, the U.S. stock market presents a mixed landscape, with the Dow Jones advancing while sectors like semiconductors weigh heavily on the Nasdaq. Amidst these fluctuations, identifying stocks that are potentially undervalued becomes crucial for investors looking for opportunities that may not yet reflect their intrinsic worth in their current market prices.